Brooklyn, NY, United States of America

Ontario D Lau

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Rockefeller University. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ontario D Lau. Retrieved from https://idiyas.com/inventor/ontario-d-lau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ontario D Lau: Innovator in Histone Acetyltransferase Inhibitors

Introduction

Ontario D Lau is a prominent inventor based in Brooklyn, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for histone acetyltransferases (HATs). His work has implications for therapeutic processes in human medicine.

Latest Patents

Ontario D Lau holds a patent titled "Inhibitors of histone acetyltransferases (HATs) and uses thereof." This patent focuses on histone acetyltransferase inhibitors that differentiate between p300 and PCAF histone acetyltransferases. The therapeutic processes involving the administration of these inhibitors to humans are also covered in this patent. He has 1 patent to his name.

Career Highlights

Ontario D Lau is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing our understanding of histone acetylation and its role in gene regulation.

Collaborations

Ontario has collaborated with notable scientists in his field, including Philip A Cole and Raymond E Soccio. These collaborations have further enriched his research and contributed to the scientific community.

Conclusion

Ontario D Lau is a key figure in the development of histone acetyltransferase inhibitors, with a focus on therapeutic applications. His contributions to biochemistry continue to impact the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…